The Human Genome Project gave scientists the ability to "read" DNA. But the real opportunities, they say, lie in our ability to not only read genetic code, but also to write it, and then build it. Synthetic biology - a new frontier in bioengineering - works because biological creatures can be seen as programmable manufacturing systems. Dr. Drew Endy, Assistant Professor of Bioengineering at Stanford School of Medicine and president of BioBricks Foundation, wants to take control of a cell's genetic machinery to make cells that can follow different programs. These programs would allow the manufactured cell to scan for chemical signals of cancer and help scientists produce a drug to target the cancer directly. Endy, a leader in the field of synthetic biology and one of the White House's Champions of Change, wants to revolutionize the way we detect and combat disease. Hear what he has to say in this live forum moderated by Lisa Krieger, science writer for the San Jose Mercury News
* Additional fees apply. No coupon or promo codes necessary to enjoy the displayed discount price.